Видео ютуба по тегу Dasatinib

Nonalcoholic fatty liver disease is worsened by dasatinib and quercetin
Nonalcoholic fatty liver disease is worsened by dasatinib and quercetin
Dasatinib in the Second-Line Setting
Dasatinib in the Second-Line Setting
SPIRIT2 trial on dasatinib for AML - safety and side effect management
SPIRIT2 trial on dasatinib for AML - safety and side effect management
Successful TFR in DASFREE: dasatinib for R/R CML
Successful TFR in DASFREE: dasatinib for R/R CML
Dasatinib-blinatumomab combination for the front-line treatment of adult Ph-positive ALL patients
Dasatinib-blinatumomab combination for the front-line treatment of adult Ph-positive ALL patients
Dasatinib vs imatinib in the treatment of paediatric ALL
Dasatinib vs imatinib in the treatment of paediatric ALL
Dasatinib plus intensive chemo versus stem cell transplant for Philadelphia chromosome positive ALL
Dasatinib plus intensive chemo versus stem cell transplant for Philadelphia chromosome positive ALL
Dasatinib-blinatumomab for ALL
Dasatinib-blinatumomab for ALL
Effects of dasatinib on xenograft lung tumour models with YES1 overexpression
Effects of dasatinib on xenograft lung tumour models with YES1 overexpression
Asciminib plus dasatinib for the treatment of Ph+ B-ALL: insights from a Phase I trial
Asciminib plus dasatinib for the treatment of Ph+ B-ALL: insights from a Phase I trial
Dasatinib response in AML
Dasatinib response in AML
Comparing dasatinib-blinatumomab vs ponatinib-blinatumomab in newly diagnosed Ph+ B-ALL
Comparing dasatinib-blinatumomab vs ponatinib-blinatumomab in newly diagnosed Ph+ B-ALL
Update on dasitinib from DASISION and SPIRIT2 trials for CML
Update on dasitinib from DASISION and SPIRIT2 trials for CML
Dasatinib prednisone induction prior to transplant for Ph+ ALL
Dasatinib prednisone induction prior to transplant for Ph+ ALL
Dasatinib plus nivolumab in patients with previously treated CML
Dasatinib plus nivolumab in patients with previously treated CML
Dual ABL1 inhibition in elderly ALL: asciminib, dasatinib, prednisone
Dual ABL1 inhibition in elderly ALL: asciminib, dasatinib, prednisone
What are the efficacy and safety considerations of dasatinib therapy?
What are the efficacy and safety considerations of dasatinib therapy?
Dasatinib vs imatinib for paediatric Ph+ALL
Dasatinib vs imatinib for paediatric Ph+ALL
Kris Griffin speaks about his experience changing from imatinib to dasatinib
Kris Griffin speaks about his experience changing from imatinib to dasatinib
D-ALBA update: Frontline sequential dasatinib and blinatumomab in adult Ph+ ALL
D-ALBA update: Frontline sequential dasatinib and blinatumomab in adult Ph+ ALL